Johnson & Johnson (
) will begin trading ex-dividend on February 22, 2013. A cash
dividend payment of $0.61 per share is scheduled to be paid on
March 12, 2013. Shareholders who purchased JNJ stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
marks the 4th quarter that JNJ has paid the same dividend.
The previous trading day's last sale of JNJ was $76.96,
representing a -0.05% decrease from the 52 week high of $77 and a
24.71% increase over the 52 week low of $61.71.
JNJ is a part of the Consumer Durables sector, which includes
companies such as Pfizer, Inc. (
) and Novartis AG (
). JNJ's current earnings per share, an indicator of a company's
profitability, is $3.87. Zacks Investment Research reports JNJ's
forecasted earnings growth in 2013 as 6.16%, compared to an
industry average of -.1%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to JNJ through an Exchange
Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- First Trust Morningstar Dividend Leaders Index Fund (
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
- Vanguard Health Care ETF (
- Merrill Lynch Pharmaceutical HOLDRS (
The top-performing ETF of this group is XLV with an increase of
8.68% over the last 100 days. FDL has the highest percent weighting
of JNJ at 9.67%.